‘Fill and Finish’ Covid-19 Vaccine Facility in Duopharma by Mr Leon Cruz AL Francis Cruz (Head of Sterile Production, Duopharma Biotech)
‘Fill and Finish’ Covid-19 Vaccine Facility in Pharmaniaga by Mr Abdul Malik Mohamed (Director of Logistics & Distribution, Pharmaniaga Logistics Sdn Bhd)
1. Welcoming Address by Zarina Noordin (ISPE Malaysia President)
2. Vaccine Landscape Current Trends and Emerging Themes by Dr. Khor Swee Kheng (Health Policies Specialist)
3. Vaccine Manufacturing and Technology Strategy by Michelle Peake (SeerPharma Pty. Ltd.)
4. Vaccine Development in Malaysia by Dr. Mohd Nor Azman bin Hassan (MOSTI)
5. Virtual Vaccine Manufacturing Plant Tour by Thailand Government Pharmaceutical Organisation (GPO)
6. Facility Design Considerations for Vaccine Manufacturing by Don Grubb and Mark Dobson (Rieckermann (Malaysia) Sdn Bhd)
7. Single Use Systems for Biomanufacturing by Apala Banerjee (Sartorius India)
8. Quality Control for Vaccines by Dr Suttida Puksuriwong (The Government Pharmaceutical Organization (Thailand))
9. Product Registration Requirements and Process for Vaccines Approvals by Product Registration Requirements and Process for Vaccines Approvals
10. Clinical Trials of Vaccines in Malaysia by Dr Akhmal Yusof (Chief Executive Officer, Clinical Research Malaysia)
11. Lots Release of Vaccines by Ms Maslinda Mahat
12. Vaccines Storage- Design, Qualification and Monitoring by Vaccines Storage Design, Qualification and Monitoring
13. Closing Remark by Mr Fadzhairi Jabar (ISPE Malaysia Vice President, Intervenn Biosciences)
Accelerating Vaccine Development and Manufacturing Capabilities through Collaborations by Ms Josephine Cheng (Merck)
Platform Technologies Speeding Up Novel Vaccines Development and Manufacturing by Ms Josephine Cheng (Merck)
Understanding mRNA Vaccine Modality by Dr Subhasis Banerjee (Merck Life Sciences)
Vaccines Development – Preclinical Studies by Dr. Mallikarjun Narayan Dixit (Bioneeds India Private Limited)
